Clinical Trial Update: MAPS Trial: Matrix And Platinum Science [Phase 4]

View source ↗

Summary

Phase 4 MAPS trial by Stryker Neurovascular evaluating Matrix and Platinum Science for intracranial aneurysms has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Aneurysms

Snippet

Sponsor: Stryker Neurovascular | Conditions: Intracranial Aneurysms | Phase 4 | Status: COMPLETED | Results posted: 2014-03-18